Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BAP
|
|||
| Former ID |
DIB007982
|
|||
| Drug Name |
KUR-212
|
|||
| Synonyms |
I-020502; Fibrin-PDGF (wound healing), Baxter/Kuros; Fibrin-recombinant human platelet-derived growth factor (wound healing), Baxter/Kuros
Click to Show/Hide
|
|||
| Indication | Wound healing [ICD-11: EL8Y] | Phase 2 | [1] | |
| Company |
Baxter International Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fibrin (FG) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00471939) Safety and Efficacy of I-020502 in Meshed Skin Autografting. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Kuros. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.